Saroja Pharma Industries India Ltd
NSE: SAROJA
₹32.30
₹0.00 (0.00%)As on 12-Jun-2026 09:07IST
Market cap
₹13 Cr
Revenue (TTM)
₹54 Cr
P/E Ratio
8
P/B Ratio
0.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹1 Cr
-
ROE
6.8 %
-
ROCE
12.6 %
-
Industry P/E
25.87
-
EV/EBITDA
5.8
-
Debt to Equity
0.6
-
Book Value
₹39
-
EPS
₹2.6
-
Face value
10
-
Shares outstanding
4,020,486
5 Years Aggregate
CFO
₹-0.35 Cr
EBITDA
₹11.47 Cr
Net Profit
₹4.84 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Saroja Pharma Ind
| -19.3 | -- | -3.4 | -17.5 | -- | -- | -- |
|
BSE Commodities
| 6.1 | -1.4 | 7.2 | 9.1 | 16.2 | 10.1 | 15.4 |
|
Company
|
2025
|
2024
|
|---|---|---|
|
Saroja Pharma Ind
| -31.4 | 13.1 |
|
BSE Small Cap
| -6.6 | 29.0 |
|
BSE Commodities
| 12.5 | 8.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Saroja Pharma Ind
|
32.3 | 13.0 | 53.7 | 1.0 | -- | 6.8 | 8 | 0.8 |
| 8.5 | 391.0 | 342.9 | 6.0 | 2.7 | 11.7 | 65.3 | 7.2 | |
| 120.4 | 55.4 | 59.3 | -0.6 | -7.6 | 0.1 | -- | 1.1 | |
| 9.7 | 23.9 | 67.5 | 1.2 | -0.1 | 9.9 | 19.7 | 1.8 | |
| 221.0 | 139.6 | 18.8 | 18.0 | 4.8 | 3.9 | 7.8 | 0.3 | |
| 2.3 | 7.8 | 0.0 | -2.9 | -- | -- | -- | 0.2 | |
| 16.9 | 26.1 | 0.6 | -7.3 | -207.7 | -- | -- | -0.4 | |
| 28.7 | 9.4 | 9.6 | 0.4 | 4.8 | 14.2 | 24.8 | 5.8 | |
| 103.1 | 713.2 | 32.0 | 20.7 | -13.8 | 0.8 | 34.4 | 0.3 | |
| 244.6 | 446.1 | 652.4 | 16.5 | 1.7 | 12.8 | 27 | 3.4 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Saroja Pharma Ind
Pharma APIs
-
Incorporated
2019
-
Chairman
Biju Nair
-
Managing Director
Biju Nair
-
Headquarters
Mumbai, Maharashtra
-
Website
Looking for more details about Saroja Pharma Industries India Ltd’s IPO? Explore our IPO Details page.
FAQs for Saroja Pharma Ind
What is the current share price of Saroja Pharma Industries India Ltd Today?
The share price of Saroja Pharma Industries India Ltd is ₹32.30 (NSE) as of 12-Jun-2026 09:07 IST. Saroja Pharma Industries India Ltd has given a return of -17.5% in the last 1 years.
What is the current PB & PE ratio of Saroja Pharma Industries India Ltd?
The P/E ratio of Saroja Pharma Industries India Ltd is 8.03 times as on 11-Jun-2026, a 69 discount to its peers’ median range of 25.87 times.
The P/B ratio of Saroja Pharma Industries India Ltd is 0.83 times as on 11-Jun-2026, a 55 discount to its peers’ median range of 1.84 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
14.68
|
0.97
|
|
2024
|
16.07
|
0.96
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Saroja Pharma Industries India Ltd?
The 52-week high and low of Saroja Pharma Industries India Ltd are Rs 60.00 and Rs 0.00 as of 15-Jun-2026.
What is the market cap of Saroja Pharma Industries India Ltd?
Saroja Pharma Industries India Ltd has a market capitalisation of ₹ 13 Cr as on 11-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Saroja Pharma Industries India Ltd?
Before investing in Saroja Pharma Industries India Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.